Physician profile
Asma Jamil
NPI 1598206740
$2,853.54
in general payments reported to CMS, 2019-2025
16 companies · $713 in 2025
The $713 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $45.41 · 2021: $19.43 · 2022: $216 · 2023: $839 · 2024: $1,020 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,394 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,393.60 |
| Education | $178.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,221.20 | 2022-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals Lp | $471.77 | 2023-2025 | Fasenra, Tezspire, Breztri |
| Actelion Pharmaceuticals US, INC. | $271.15 | 2023-2024 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.57 | 2023-2025 | Ofev, Jascayd |
| Genzyme Corporation | $197.02 | 2023-2025 | |
| United Therapeutics Corporation | $122.44 | 2023-2025 | Tyvaso, Tyvaso, Orenitram |
| Gilead Sciences, INC. | $76.41 | 2023-2024 | Epclusa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.41 | 2020 | |
| Janssen Pharmaceuticals, INC | $34.43 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $30.83 | 2023-2025 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $28.67 | 2022-2023 | |
| Electromed, INC. | $27.92 | 2025 | Smartvest |
| Inogen, INC. | $26.30 | 2025 | |
| Pulmonx Corporation | $25.75 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Verona Pharma, INC. | $18.05 | 2025 | Ohtuvayre |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $16.62 | 2025 | Vest Therapy Und |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asma Jamil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.